Morgan Stanley Qilian International Holding Group LTD Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.41 - $0.69 $735 - $1,237	1,794 New	1,794 $1,000
Q4 2023 Aug 16, 2024	BUY	$0.38 - $0.81 $681 - $1,453	1,794 New	1,794 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.14 - $6.1 $2,280 - $12,200	-2,000 Reduced 52.71%	1,794 $2,000
Q2 2022 Oct 27, 2022	SELL	$1.4 - $2.0 $7,000 - $10,000	-5,000 Reduced 56.86%	3,794 $8,000
Q2 2022 Aug 15, 2022	SELL	$1.4 - $2.0 $7,000 - $10,000	-5,000 Reduced 56.86%	3,794 $8,000
Q1 2022 Oct 27, 2022	BUY	$1.57 - $2.68 $7,850 - $13,400	5,000 Added 131.79%	8,794 $15,000
Q3 2021 Nov 15, 2021	BUY	$3.92 - $4.35 $34,472 - $38,253	8,794 New	8,794 $36,000

Ticker QLI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 35,750,000
Market Cap $240M
Description
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Ext...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.